Cocrystal Pharma's Reforms To End $27M Stock Plot Suits
Cocrystal Pharma Inc. will implement a series of corporate reforms to settle three derivative suits brought by shareholders over an alleged $27 million pump-and-dump scheme that drove down the value of...To view the full article, register now.
Already a subscriber? Click here to view full article